Skip to content

Cybersecurity in Laboratory Medicine: The Risks

The increasing digitalization and networking in laboratory medicine, alongside many advantages, also bring new security risks. Medical laboratories have become attractive targets for cyberattacks due to their critical role in healthcare and the sensitive data they process. Current Threat Landscape Laboratories face a variety of cyber threats: – Ransomware attacks: Criminals encrypt laboratory data and demand ransom for its release. Such an attack can paralyze laboratory operations and endanger patient care[1]. – Data theft: Sensitive patient data and research results are valuable to cybercriminals. An example is the attack on LifeLabs in Canada in 2019, where data from 15 million customers was stolen[2]. – Device manipulation: Attackers could attempt to manipulate laboratory devices, thereby falsifying test results. In 2021, a vulnerability was discovered in infusion pumps that allowed remote manipulation of medication dosage[6]. Vulnerabilities in Laboratory Infrastructure Several factors make laboratories particularly vulnerable: 1.… 

more »Cybersecurity in Laboratory Medicine: The Risks

5,000 new positions in health authorities reached

The federal government has already nearly achieved its goal set during the Corona pandemic of creating and filling 5,000 new positions in public health offices by the end of 2025. According to the Federal Ministry of Health, as reported by the newspapers of the “Redaktionsnetzwerk Deutschland,” the staff in the public health service has been increased by 4,833 employees nationwide so far. Among these are, according to the information [...] Almost 5,000 new positions in public health offices reached

General practitioners warn of overburdened practices due to infection wave

The German general practitioners are warning of acute supply bottlenecks this autumn. The practices are already heavily burdened this year by a high infection wave, and the strain is already very high, said the federal chairwoman of the Association of General Practitioners, Nicola Buhlinger-Göpfarth, to the newspapers of the Funke Media Group. Given the tense situation in the practices, one must expect that more and more practices [...] General practitioners warn of overburdened practices due to infection wave

Medtronic and Siemens Healthineers cooperate

Medtronic and Siemens Healthineers have entered into a partnership to expand access to pre- and postoperative imaging technologies for spine surgery, the companies said Wednesday at the North American Spine Society annual meeting. The firms will jointly market Siemens Healthineers' Multitom Rax X-ray imaging system and integrate it into Medtronic's AiBLE product line for spine surgery. Skip Kiil, Medtronic's president of cranial and spine technologies, said in a statement that the partnership is intended to reduce variability and improve patient outcomes. https://news.medtronic.com/2024-09-25-Medtronic-expands-AiBLE-TM-spine-surgery-ecosystem-with-new-technologies-and-Siemens-Healthineers-partnership

GOÄ Amendment: DGKL fears laboratory medicine collapse

Bad news for Germany's laboratory medicine: The German Society for Clinical Chemistry and Laboratory Medicine (DGKL) sharply criticized the planned GOÄ amendment at the German Congress for Laboratory Medicine in Bremen. The amendment provides for significant cuts in the remuneration of laboratory medicine. A model calculation for a university hospital showed "that the amendment would mean losses of more than a quarter in the inpatient sector and even 40 percent in the outpatient sector." The planned remuneration structure would weaken laboratories that ensure 24/7 availability – i.e., in hospitals and university hospitals. This threatens a collapse of central areas of medical advancement. A weakening of laboratory medicine would have unforeseeable consequences for healthcare in Germany. A good two-thirds of all diagnoses are ultimately based on laboratory results. Laboratory medicine is of central importance in personalized medicine and has made massive progress in patient care in recent years... 

more »GOÄ Amendment: DGKL fears laboratory medicine collapse

Increase in mycoplasma infections worries experts

  • News

In Germany and worldwide, health experts are noting a worrying increase in Mycoplasma infections[1][2]. These bacterial pathogens, which can cause severe pneumonia, are increasingly appearing alongside well-known viral diseases such as Corona and Influenza. Current Situation Thomas Preis, Chairman of the North Rhine Pharmacists Association, confirms the significant increase in Mycoplasma infections[1][2]. Dresden biologist Roger Dumke emphasizes the seriousness of the situation, pointing out that not only the number of cases is increasing, but also the proportion of severe disease courses is rising[1][2]. Health Risks Mycoplasmas are bacteria that have the potential to cause severe pneumonia[1][2]. The increasing spread of these pathogens presents new challenges for the healthcare system, especially in times when other respiratory diseases are already circulating. Call for Vigilance In light of this development, health experts are calling for increased attention. Patients with symptoms of a respiratory infection should seek medical advice to ensure timely diagnosis and appropriate treatment. The situation… 

more »Increase in Mycoplasma infections worries experts

Pharmaceutical industry dominates clinical cancer research in the USA

Researchers at the Fred Hutch Cancer Center have observed a significant increase in the proportion of cancer patients in the US participating in industry-sponsored clinical trials over the past decade, compared to trials conducted with federal government support. These findings were published in the Journal of Clinical Oncology and presented at the ASCO Quality Care Symposium. They reveal trends of underinvestment in government-funded trials, stagnant enrollment in government-funded trials for over a decade, and a growing reliance on industry for conducting cancer research. The study showed that between 2018 and 2022, industry-sponsored trials enrolled more than eight times as many patients as government-funded trials. For trials involving adults, industry enrolled nearly ten times as many patients. These ratios have also increased significantly over time. Compared to the decade… 

more »Pharmaceutical industry dominates clinical cancer research in the USA

Mayo Clinic Minute: The vital role of phlebotomists in blood collection

Phlebotomy technicians collect blood from patients and prepare the samples for testing. Most work in hospitals and clinics, but some collect blood for donation purposes. In this Mayo Clinic Minute, Dr. Fiona Craig, who oversees the Laboratory Medicine and Pathology Department at Mayo Clinic in Arizona, discusses the vital role phlebotomists play in blood collection. Watch: The Mayo Clinic Minute

Salmonella: Arugula can be deadly

In Germany, a current salmonella outbreak is causing concern, which is highly likely to be due to contaminated arugula. The Robert Koch Institute (RKI) reports a significant increase in infections with the rare pathogen Salmonella Umbilo[1][2]. Unusually High Case Numbers By September 24, 2024, 98 cases of illness had already been registered in Germany. This represents a drastic increase compared to previous years, when only one to six cases per year were recorded[1][3]. Almost all federal states are affected, with the exception of Bremen and Saarland[2]. Arugula as the Probable Source Due to the nationwide occurrence of cases, the RKI suspects a widely distributed food item as the cause. Surveys of those affected and investigations in Austria, where Salmonella Umbilo was detected in samples of Italian arugula, strengthen the suspicion that contaminated arugula is the main source of the infections[1][3]. Symptoms and Risks A salmonella infection typically manifests as: – Diarrhea– Abdominal pain… 

more »Salmonella: Arugula can be deadly

Swedish research on antibiotic pollution becomes UN declaration after 17 years

In 2007, researchers at the University of Gothenburg, Sweden, published the first in a series of studies showing massive pollution with antibiotics from pharmaceutical factories in India. In connection with the ongoing UN General Assembly in New York, a declaration was approved that underlines the risks and calls for measures to reduce pollution. – The UN declaration is an important contribution to the fight against antibiotic resistance, not the least because it underscores the role of the environment and identifies several necessary actions, says Joakim Larsson, professor in environmental pharmacology at the Sahlgrenska Academy, University of Gothenburg, Sweden. Two of the items in the UN declaration, 76 and 91, specifically address the industrial discharges. Here, the research from the University of Gothenburg has played a critical role. Rocket-high concentrations of antibiotics The wastewater and the polluted waterways in India investigated by Joakim Larsson… 

more »Swedish research on antibiotic pollution becomes UN declaration after 17 years